MIST
Milestone Pharmaceuticals Inc.
NASDAQHealthcareBiotechnologyCA
Rating:C-
Company Profile
CEO
Joseph G. Oliveto
IPO Date
2019-05-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
CA
Milestone Pharmaceuticals Inc.
CEO
Joseph G. Oliveto
IPO Date
2019-05-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
CA
| 77,000 |
| $1.22 |
| 12 Jun 2026 | Duty Stuart | director | A-Award | Acquired | 77,000 | $1.22 |
| 12 Jun 2026 | Wills Robert James | director | A-Award | Acquired | 77,000 | $1.22 |
| 12 Jun 2026 | TOMSICEK MICHAEL JOHN | director | A-Award | Acquired | 77,000 | $1.22 |
| 12 Jun 2026 | Saik Andrew | director | A-Award | Acquired | 77,000 | $1.22 |
| 12 Jun 2026 | PAPA JOSEPH C | director | A-Award | Acquired | 77,000 | $1.22 |
| 20 Apr 2026 | Oliveto Joseph | director, officer: President and CEO | S-Sale | Disposed | 36,500 | $2.26 |
| 23 Mar 2026 | Sandoval David I. | GC & Chief Compliance Officer | Disposed | 400,000 | $1.96 |
| 5 Feb 2026 | Oliveto Joseph | director, officer: President and CEO | A-Award | Acquired | 679,000 | $1.96 |